These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38683728)

  • 21. Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience.
    Wang H; Hao L; Wang X; Li J; Wu Q; Bian S
    Int J Hematol; 2010 Jun; 91(5):820-5. PubMed ID: 20461563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for the treatment of acute promyelocytic leukemia.
    Frankfurt O; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):37-50. PubMed ID: 16403403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial.
    Russell N; Burnett A; Hills R; Betteridge S; Dennis M; Jovanovic J; Dillon R; Grimwade D;
    Blood; 2018 Sep; 132(13):1452-1454. PubMed ID: 30097508
    [No Abstract]   [Full Text] [Related]  

  • 24. Alternate application of all-trans-retinoic acid and arsenic trioxide combined with idarubicin/daunorubicin in treatment of acute promyelocytic leukemia.
    Xu X; Mao Y; Zhu X; Tang F
    Pak J Pharm Sci; 2022 Jan; 35(1):23-28. PubMed ID: 35221268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute promyelocytic leukemia in childhood.
    Gregory J; Feusner J
    Curr Oncol Rep; 2009 Nov; 11(6):439-45. PubMed ID: 19840521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia.
    Kulkarni UP; Selvarajan S; Lionel S; Prakash MA; Palani HK; Balasundaram N; Venkataraman A; Korula A; Devasia AJ; Fouzia NA; Janet NB; Nair SC; Abraham A; Mani T; Lakshmanan J; Arunachalam AK; Balasubramanian P; George B; Mathews V
    Blood Cancer J; 2022 Jan; 12(1):22. PubMed ID: 35102152
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations].
    Creutzig U; Dworzak M; von Neuhoff N; Rasche M; Reinhardt D
    Klin Padiatr; 2018 Oct; 230(6):299-304. PubMed ID: 30399642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukemia specific chimeric protein as a target molecule for chemotherapy].
    Naoe T
    Rinsho Ketsueki; 1998 Feb; 39(2):105-6. PubMed ID: 9545811
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of PML/RARalpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients. MRC Adult Leukaemia Working Party.
    Iqbal S; Grimwade D; Chase A; Goldstone A; Burnett A; Goldman JM; Swirsky D
    Leukemia; 2000 May; 14(5):950-3. PubMed ID: 10803535
    [No Abstract]   [Full Text] [Related]  

  • 30. CPSF6-RARG-positive acute myeloid leukaemia resembles acute promyelocytic leukaemia but is insensitive to retinoic acid and arsenic trioxide.
    Li J; Yan WZ; Bai LH; Jiang YF; Peng HL; Shen JK; Li RJ
    Pathology; 2023 Apr; 55(3):407-412. PubMed ID: 36241556
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia.
    Xiao M; Zhou P; Sun K
    Clin Appl Thromb Hemost; 2022; 28():10760296221080166. PubMed ID: 35187963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia.
    Malfuson JV; Konopacki J; Fagot T; Desangles F; Bories D; Souleau B; de Revel T
    Ann Hematol; 2011 Dec; 90(12):1477-9. PubMed ID: 21350831
    [No Abstract]   [Full Text] [Related]  

  • 34. Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.
    Rhee JY; Tremblay D; Chan AM; Tallman MS; Mascarenhas J
    Blood Adv; 2019 Jun; 3(12):1854-1857. PubMed ID: 31213431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptic t(15;17) acute promyelocytic leukemia with a karyotype of add(11)(p15) and t(13,20)- A case report with a literature review.
    Gu S; Zi J; Ma J; Ge Z
    Bosn J Basic Med Sci; 2021 Apr; 21(2):246-251. PubMed ID: 33052080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scrotal Ulcers Arising during Treatment with All-trans Retinoic Acid for Acute Promyelocytic Leukemia.
    Shimizu D; Nomura K; Matsuyama R; Matsumoto Y; Ueda K; Masuda K; Taki T; Nishida K; Horiike S; Kishimoto S; Yanagisawa A; Taniwaki M
    Intern Med; 2005 May; 44(5):480-3. PubMed ID: 15942099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a complex (11;17;15) translocation in acute promyelocytic leukemia.
    Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):93-4. PubMed ID: 16271965
    [No Abstract]   [Full Text] [Related]  

  • 38. Scrotal Ulceration and Pyrexia.
    Foley CC; Marren P
    JAMA Dermatol; 2017 Nov; 153(11):1181-1182. PubMed ID: 28724120
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy.
    Ravandi F
    Leuk Lymphoma; 2009 Jul; 50(7):1073-4. PubMed ID: 19557628
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse.
    Kulkarni UP; Selvarajan S; Fouzia NA; Lionel S; Nair SC; Balasubramanian P; Mani T; Abraham A; George B; Mathews V
    Blood Cancer J; 2023 Jun; 13(1):94. PubMed ID: 37349334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.